We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

150 hedge funds and large institutions have $2.87B invested in Legend Biotech in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more call options, than puts

Call options by funds: $47.7M | Put options by funds: $15.5M

55% more capital invested

Capital invested by funds: $1.85B → $2.87B (+$1.02B)

45% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 22

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

6% more funds holding

Funds holding: 141 → 150 (+9)

0.39% more ownership

Funds ownership: 16.7% → 17.09% (+0.39%)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

Holders
150
Holders Change
+9
Holders Change %
+6.38%
% of All Funds
2.53%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
32
Increased
50
Reduced
50
Closed
22
Calls
$47.7M
Puts
$15.5M
Net Calls
+$32.2M
Net Calls Change
+$25.8M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$179M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$32M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$24M
4
ITP
Iron Triangle Partners
Connecticut
+$20.9M
5
SC
Samlyn Capital
New York
+$19.2M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$106M
2
BBA
Baker Bros. Advisors
New York
-$48.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$25.9M
4
PA
Perceptive Advisors
New York
-$22.4M
5
CII
Capital International Inc
California
-$22.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
National Pension Service
126
National Pension Service
South Korea
$275K +$171K +4,048 +429%
PCP
127
Proficio Capital Partners
Massachusetts
$275K +$211K +5,000 New
VOYA Investment Management
128
VOYA Investment Management
Georgia
$263K +$202K +4,782 New
Nomura Asset Management
129
Nomura Asset Management
Japan
$248K – – –
ProShare Advisors
130
ProShare Advisors
Maryland
$228K -$59.8K -1,416 -25%
Nomura Holdings
131
Nomura Holdings
Japan
$215K +$167K +3,957 New
LSA
132
Leonteq Securities AG
Switzerland
$179K -$18.9K -448 -12%
Ensign Peak Advisors
133
Ensign Peak Advisors
Utah
$116K – – –
Macquarie Group
134
Macquarie Group
Australia
$91K -$44.4K -1,052 -39%
FIA
135
FNY Investment Advisers
New York
$56K +$43.7K +1,034 New
Osaic Holdings
136
Osaic Holdings
Arizona
$50K +$38.3K +906 New
ADL
137
Asset Dedication LLC
California
$42K – – –
AIG
138
American International Group
New York
$33K +$25.3K +600 New
PCH
139
Polar Capital Holdings
United Kingdom
$31.6K +$8.41M +199,217 +53%
GWS
140
Glassman Wealth Services
Virginia
$19K +$4.43K +105 +44%
CI Investments Inc
141
CI Investments Inc
Ontario, Canada
$16K -$18.5K -437 -60%
BIA
142
Bell Investment Advisors
California
$14K +$10.9K +258 New
US Bancorp
143
US Bancorp
Minnesota
$13K – – –
Daiwa Securities Group
144
Daiwa Securities Group
Japan
$11K -$191K -4,517 -96%
SOW
145
State of Wyoming
Wyoming
$9K +$422 +10 +6%
S
146
SignatureFD
Georgia
$8K – – –
PNC Financial Services Group
147
PNC Financial Services Group
Pennsylvania
$7K +$1.77K +42 +52%
AssetMark Inc
148
AssetMark Inc
California
$5K – – –
IBT
149
International Biotechnology Trust
United Kingdom
$4.5K -$180K -4,252 -94%
Group One Trading
150
Group One Trading
Illinois
$4K -$164K -3,890 -98%
3 4 5
6
7

LEGN Hedge Fund Activity: Q2 2022 in Review

150 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q2 2022, worth a combined $2.87B — up 55% from $1.85B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new LEGN positions and 22 closed out — a net gain of 10 holders — while 50 added to existing stakes and 50 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $179M. The largest seller was HHLR Advisors, cutting an estimated $106M.

  • 150 institutional investors held Legend Biotech (LEGN) as of Q2 2022, up from 141 in Q1 2022.
  • Funds reported $2.87B of Legend Biotech stock for Q2 2022, up 55% quarter-over-quarter.
  • 32 funds opened new Legend Biotech positions in Q2 2022 and 22 closed out, a net change of +10 holders.
  • The largest Legend Biotech buyer in Q2 2022 was Fidelity Investments, an estimated $179M added.
  • The largest Legend Biotech seller in Q2 2022 was HHLR Advisors, an estimated $106M sold.

Based on aggregated 13F filings for Q2 2022.